Published in J Pharm Biomed Anal on April 01, 2003
Sensitive indirect spectrophotometric method for determination of h2-receptor antagonists in pharmaceutical formulations. Int J Biomed Sci (2007) 0.75
Sensitive and selective spectrophotometric determination of gabapentin in capsules using two nitrophenols as chromogenic agents. Int J Anal Chem (2011) 0.75
On the protein (tyrosine)-chromophore (protonated Schiff base) coupling in bacteriorhodopsin. Proc Natl Acad Sci U S A (1984) 2.52
Protein catalysis of the retinal subpicosecond photoisomerization in the primary process of bacteriorhodopsin photosynthesis. Science (1993) 1.75
Picosecond resonance Raman spectroscopic evidence for excited-state spin conversion in carbonmonoxy-hemoglobin photolysis. Proc Natl Acad Sci U S A (1981) 1.29
Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol (2004) 1.28
Subpicosecond resonance Raman spectra of the early intermediates in the photocycle of bacteriorhodopsin. Biophys J (1990) 1.26
Evidence for the involvement of more than one metal cation in the Schiff base deprotonation process during the photocycle of bacteriorhodopsin. Proc Natl Acad Sci U S A (1987) 1.22
Time-resolved resonance Raman spectroscopy of intermediates of bacteriorhodopsin: The bK(590) intermediate. Proc Natl Acad Sci U S A (1979) 1.21
Time-resolved resonance Raman characterization of the bL550 intermediate and the two dark-adapted bRDA/560 forms of bacteriorhodopsin. Biophys J (1979) 1.14
On the molecular mechanisms of the Schiff base deprotonation during the bacteriorhodopsin photocycle. Proc Natl Acad Sci U S A (1986) 1.11
Importance of bound divalent cations to the tyrosine deprotonation during the photocycle of bacteriorhodopsin. Proc Natl Acad Sci U S A (1985) 1.10
Time-resolved resonance Raman spectroscopy of bacteriorhodopsin. Nature (1977) 1.08
Nature of the individual Ca binding sites in Ca-regenerated bacteriorhodopsin. Biophys J (1992) 1.08
Enhanced spectrophotometric determination of two antihyperlipidemic mixtures containing ezetimibe in pharmaceutical preparations. Drug Test Anal (2010) 1.06
The relaxation dynamics of the excited electronic states of retinal in bacteriorhodopsin by two-pump-probe femtosecond studies. Proc Natl Acad Sci U S A (2001) 1.04
Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations. J Pharm Biomed Anal (2002) 1.04
Primary step in the bacteriorhodopsin photocycle: photochemistry or excitation transfer? Proc Natl Acad Sci U S A (1981) 1.03
Time-resolved Fourier transform infrared spectroscopy of the polarizable proton continua and the proton pump mechanism of bacteriorhodopsin. Biophys J (2001) 1.02
Resonance Raman kinetic spectroscopy of bacteriorhodopsin on the microsecond time scale. Biophys J (1977) 1.00
Determination of some histamine H1-receptor antagonists in dosage forms. J Pharm Biomed Anal (2002) 0.96
CD spectrum of bacteriorhodopsin: Best evidence against exciton model. Biophys J (1991) 0.96
Time-resolved resonance Raman spectroscopy of bacteriorhodopsin on the millisecond timescale. Proc Natl Acad Sci U S A (1977) 0.95
Spectrophotometric determination of binary mixtures of pseudoephedrine with some histamine H1-receptor antagonists using derivative ratio spectrum method. J Pharm Biomed Anal (2003) 0.90
Temperature-jump investigations of the kinetics of hydrogel nanoparticle volume phase transitions. J Am Chem Soc (2001) 0.90
Aggregation of gold nanoframes reduces, rather than enhances, SERS efficiency due to the trade-off of the inter- and intraparticle plasmonic fields. Nano Lett (2009) 0.89
Photocatalysis in gold nanocage nanoreactors. J Phys Chem A (2009) 0.88
Time-resolved resonance Raman characterization of the bO640 intermediate of bacteriorhodopsin. Reprotonation of the Schiff base. Biochemistry (1979) 0.88
Circular dichroism and photocycle kinetics of partially detergent solubilized and partially retinal regenerated bacteriorhodopsin. Biophys J (1991) 0.87
Time-resolved protein fluorescence studies of intermediates in the photochemical cycle of bacteriorhodopsin. Proc Natl Acad Sci U S A (1981) 0.86
Temperature jump-induced secondary structural change of the membrane protein bacteriorhodopsin in the premelting temperature region: a nanosecond time-resolved Fourier transform infrared study. Biophys J (1999) 0.85
Time-resolved resonance Raman characterization of the intermediates of bacteriorhodopsin. Biophys J (1978) 0.83
Experimental evidence for the nanocage effect in catalysis with hollow nanoparticles. Nano Lett (2010) 0.82
Metallic double shell hollow nanocages: the challenges of their synthetic techniques. Langmuir (2012) 0.81
Polarographic determination of phenytoin and benzophenone (as impurity) in pharmaceutical preparations. J Pharm Biomed Anal (2002) 0.80
The effect of protein conformation change from alpha(II) to alpha(I) on the bacteriorhodopsin photocycle. Biophys J (2000) 0.80
Optical rotation of the second harmonic radiation from retinal in bacteriorhodopsin monomers in Langmuir-Blodgett film: evidence for nonplanar retinal structure. Biophys J (1997) 0.79
Bioavailability study of triamterene and xipamide using urinary pharmacokinetic data following single oral dose of each drug or their combination. J Pharm Biomed Anal (2011) 0.79
Effect of temperature, pH, and metal ion binding on the secondary structure of bacteriorhodopsin: FT-IR study of the melting and premelting transition temperatures. Biochemistry (2001) 0.78
Simultaneous multiresidue determination of metronidazole and spiramycin in fish muscle using high performance liquid chromatography with UV detection. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.78
Studies of cation binding in ZnCl2-regenerated bacteriorhodopsin by x-ray absorption fine structures: effects of removing water molecules and adding Cl- ions. Biophys J (1997) 0.77
Development and validation of spectrophotometric and HPTLC methods for simultaneous determination of rosiglitazone maleate and metformin hydrochloride in the presence of interfering matrix excipients. Drug Dev Ind Pharm (2013) 0.76
Concentrations of acidic antiinflammatory drugs in gastric mucosa. Arch Int Pharmacodyn Ther (1977) 0.76
Sucralose. Profiles Drug Subst Excip Relat Methodol (2013) 0.75
Quantitative determination of pillocarpine in crude drugs, pharmaceutical preparations and with physostigmine in combination. Pharmazie (1975) 0.75
The incidence of sugars in the urine of infants and children. Arch Dis Child (1933) 0.75
Responses of fungi to tropane alkaloids produced by a medicinal plant Hyoscyamus muticus (Egyptian henbane). Folia Microbiol (Praha) (2009) 0.75
Fluorescence anisotropy studies of dibucaine.HCl in micelles and bacteriorhodopsin. J Photochem Photobiol B (1992) 0.75
High-performance liquid chromatographic determination of proquazone and its m-hydroxy metabolite in spiked human plasma and urine. J AOAC Int (2007) 0.75
Spectrophotometric determination of certain volatile oils. Part 1: Assay for phenols in volatile oils of clove and thyme. Pharmazie (1976) 0.75
Simultaneous determination of montelukast and fexofenadine using Fourier transform convolution emission data under non- parametric linear regression method. J Fluoresc (2013) 0.75
Spektrophotometric estimation of quinine in combination with novalgine and in other pharmaceutical preparations. Pharmazie (1972) 0.75
Time dependence and signs of the shift of the surface plasmon resonance frequency in nanocages elucidate the nanocatalysis mechanism in hollow nanoparticles. Nano Lett (2011) 0.75
Differential pulse, square wave and adsorptive stripping voltammetric quantification of tianeptine in tablets. J Pharm Biomed Anal (2006) 0.75
Non-parametric linear regression of discrete Fourier transform convoluted chromatographic peak responses in non-ideal conditions. Talanta (2005) 0.75
Kinetic spectrophotometric methods for the determination of artificial sweetener (sucralose) in tablets. Drug Test Anal (2010) 0.75